Yüklüyor......
The Sclerostin-Independent Bone Anabolic Activity of Intermittent PTH Treatment Is Mediated by T-Cell–Produced Wnt10b
Both blunted osteocytic production of the Wnt inhibitor sclerostin (Scl) and increased T-cell production of the Wnt ligand Wnt10b contribute to the bone anabolic activity of intermittent parathyroid hormone (iPTH) treatment. However, the relative contribution of these mechanisms is unknown. In this...
Kaydedildi:
| Yayımlandı: | J Bone Miner Res |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326235/ https://ncbi.nlm.nih.gov/pubmed/24357520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2044 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|